Lincoln National Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-83,505
| Closed | -$15.2M | – | 26 |
|
|
2024
Q1 | $15.2M | Buy |
83,505
+3,191
| +4% | +$550K | 0.24% | 68 |
|
|
2023
Q4 | $12.4M | Buy |
80,314
+3,354
| +4% | +$489K | 0.22% | 67 |
|
|
2023
Q3 | $11.5M | Buy |
76,960
+1,692
| +2% | +$248K | 0.23% | 63 |
|
|
2023
Q2 | $10.1M | Buy |
75,268
+2,215
| +3% | +$325K | 0.2% | 69 |
|
|
2023
Q1 | $11.6M | Buy |
73,053
+4,907
| +7% | +$750K | 0.24% | 57 |
|
|
2022
Q4 | $11M | Buy |
68,146
+1,873
| +3% | +$287K | 0.25% | 54 |
|
|
2022
Q3 | $8.89M | Buy |
66,273
+8,937
| +16% | +$1.28M | 0.22% | 63 |
|
|
2022
Q2 | $8.78M | Sell |
57,336
-3,147
| -5% | -$481K | 0.21% | 69 |
|
|
2022
Q1 | $9.8M | Sell |
60,483
-542
| -0.9% | -$78.7K | 0.2% | 68 |
|
|
2021
Q4 | $8.26M | Buy |
61,025
+2,516
| +4% | +$297K | 0.17% | 73 |
|
|
2021
Q3 | $6.31M | Buy |
58,509
+2,528
| +5% | +$289K | 0.14% | 80 |
|
|
2021
Q2 | $6.31M | Buy |
55,981
+2,943
| +6% | +$331K | 0.14% | 82 |
|
|
2021
Q1 | $5.74M | Buy |
53,038
+5,965
| +13% | +$638K | 0.14% | 80 |
|
|
2020
Q4 | $5.04M | Buy |
47,073
+5,145
| +12% | +$494K | 0.13% | 81 |
|
|
2020
Q3 | $3.67M | Buy |
41,928
+1,454
| +4% | +$137K | 0.11% | 103 |
|
|
2020
Q2 | $3.97M | Buy |
40,474
+5,125
| +14% | +$451K | 0.13% | 88 |
|
|
2020
Q1 | $2.69M | Sell |
35,349
-4,608
| -12% | -$392K | 0.1% | 104 |
|
|
2019
Q4 | $3.54M | Buy |
39,957
+6,220
| +18% | +$516K | 0.11% | 94 |
|
|
2019
Q3 | $2.56M | Buy |
33,737
+5,030
| +18% | +$345K | 0.09% | 111 |
|
|
2019
Q2 | $2.09M | Buy |
28,707
+5,863
| +26% | +$461K | 0.08% | 120 |
|
|
2019
Q1 | $1.84M | Buy |
22,844
+2,055
| +10% | +$168K | 0.08% | 118 |
|
|
2018
Q4 | $1.92M | Buy |
20,789
+1,819
| +10% | +$160K | 0.09% | 104 |
|
|
2018
Q3 | $1.79M | Sell |
18,970
-7,079
| -27% | -$671K | 0.06% | 114 |
|
|
2018
Q2 | $2.41M | Sell |
26,049
-802
| -3% | -$78.3K | 0.09% | 81 |
|
|
2018
Q1 | $2.54M | Sell |
26,851
-13,298
| -33% | -$1.46M | 0.09% | 82 |
|
|
2017
Q4 | $3.88M | Buy |
40,149
+19,763
| +97% | +$1.86M | 0.12% | 88 |
|
|
2017
Q3 | $1.81M | Buy |
20,386
+447
| +2% | +$34K | 0.08% | 93 |
|
|
2017
Q2 | $1.45M | Sell |
19,939
-566
| -3% | -$38.1K | 0.07% | 94 |
|
|
2017
Q1 | $1.34M | Sell |
20,505
-466
| -2% | -$29.3K | 0.07% | 95 |
|
|
2016
Q4 | $1.31M | Buy |
20,971
+860
| +4% | +$52.5K | 0.07% | 106 |
|
|
2016
Q3 | $1.27M | Buy |
20,111
+898
| +5% | +$58.1K | 0.07% | 108 |
|
|
2016
Q2 | $1.19M | Buy |
19,213
+551
| +3% | +$33.6K | 0.07% | 107 |
|
|
2016
Q1 | $1.07M | Buy |
18,662
+9,195
| +97% | +$512K | 0.08% | 103 |
|
|
2015
Q4 | $527K | Buy |
+9,467
| New | +$545K | 0.04% | 117 |
|
Other funds holding ABBV
Lincoln National Corp's ABBV Position: Q2 2024 in Review
Lincoln National Corp sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 83,505 shares — an estimated $15.2M sold.
Lincoln National Corp first reported a position in ABBV in Q4 2015 and held it in 34 quarters. The position peaked at $15.2M in Q1 2024. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.
- Lincoln National Corp reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
- Lincoln National Corp sold 83,505 AbbVie shares in Q2 2024, an estimated $15.2M.
- Lincoln National Corp first reported a position in AbbVie in Q4 2015 and held it in 34 quarters.
- Lincoln National Corp's AbbVie position peaked at $15.2M in Q1 2024.
- 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.
Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.